Regression to the mean and predictors of MRI disease activity in RRMS placebo cohorts--is there a place for baseline-to-treatment studies in MS?

by Jan-Patrick Stellmann, Klarissa Hanja Stürner, Kim Lea Young, Susanne Siemonsen, Tim Friede, Christoph Heesen
Published 2015-01-01